Cold-cough

Commercial

Portfolio-7447-for-WEB

NCE Pipeline

Discovery-7447-for-WEB

Research

Latest Annual Report

Vernalis-AR2013-CoverApr 01, 2014

2013 Results Download our latest report...        


Archive

Latest Webcast

ceoApril 01, 2014

Our latest webcast is available to view here...


Archive

Share Price

Share price:  35.50p
Change:  0.00 (0.00%)
As at:  24 April 2014 08:17:37
Volume:  28,312
LSE ID:  VER

Share price details

Latest News

Promising Results of Phase Ib/II Proof-of-Concept Study in Attention Deficit Hyperactivity Disorder (ADHD) with V81444

Vernalis plc today announces the results from a Phase Ib/II proof-of-concept (POC) study of V81444, an A2A antagonist which has potential applications for the treatment of

Read more...

Contact Vernalis

T: 0118 938 0000
F: 0118 938 0001

Contact information
Maps and directions
Contact form